IMR Press / JIN / Volume 20 / Issue 3 / DOI: 10.31083/j.jin2003071
Open Access Short Communication
An H2-infused, nitric oxide-producing functional beverage as a neuroprotective agent for TBIs and concussions
Show Less
1 Centre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, Faculty of Natural Sciences of Comenius University, 84104 Bratislava, Slovak Republic
2 Molecular Hydrogen Institute, Cedar, UT 84720, USA
3 Department of Kinesiology and Outdoor Recreation, Southern Utah University, Cedar, UT 84720, USA
4 Corpus Performance, Judd, Dallas, TX 11837, USA
5 Medical Office, Internal Medicine, Dallas, TX 75201, USA
J. Integr. Neurosci. 2021 , 20(3), 667–676;
Submitted: 7 June 2021 | Revised: 2 August 2021 | Accepted: 11 August 2021 | Published: 30 September 2021

Traumatic brain injuries (TBIs) are a leading cause of death and disability. Sports-related TBIs are estimated to be more than several million per year. The pathophysiology of TBIs involves high levels of inflammation, oxidative stress, dysregulation of ion homeostasis, mitochondrial dysfunction, and apoptosis. There is also a reduction in cerebral blood flow, leading to hypoxia and reduced removal of metabolic waste, which further exacerbates the injury. There is currently no recognized effective medical treatment or intervention for TBIs, which may in part be due to the difficulty of drug delivery through the blood-brain barrier. Molecular hydrogen has recently emerged as a neuroprotective medical gas against cerebral infarction and neurodegenerative diseases including TBIs. Its small molecular size and nonpolar nature allow it to easily diffuse through the blood-brain barrier, cell membranes and subcellular compartments. Hydrogen has been shown to exert selective anti-inflammatory, antioxidant, and anti-apoptotic effects by regulating various transcription factors and protein phosphorylation cascades. Nitric oxide is another well-recognized medical gas that plays divergent roles in protecting from and in the recovery of TBIs, as well as in contributing to their pathophysiology and injury. Excessive activation of inducible nitric oxide synthase leads to excess inflammation and oxidative/nitrosative damage as well as a paradoxical nitric oxide depletion in the locations it is needed. Hydrogen regulates nitric oxide production and metabolism, which enhances its benefits while reducing its harms. A novel H2-infused, nitric oxide producing beverage, Hydro Shot, may have important neuroprotective benefits for TBIs. We report preliminary indications that Hydro Shot may be a meaningful adjuvant treatment for TBIs.

Traumatic brain injury
Molecular hydrogen
Nitric oxide
Reactive oxygen specie
1. Introduction

Traumatic brain injuries represent a serious health concern for millions of people and are a contributing risk factor in the development of other neurodegenerative diseases. However, there are many obstacles that need to be overcome in order to address these brain injuries including diagnosis, treatment, and monitoring. This article briefly summarizes the current status and problems with diagnosing, monitoring and treating traumatic brain injuries as well as its molecular pathophysiology. We introduce a novel approach for the treatment of traumatic brain injuries using medical gases, nitric oxide and molecular hydrogen. The scientific literature of both of these gases is briefly reviewed followed by some preliminary data in which administration of both gaseous molecules through a novel functional beverage improves cognitive function.

2. TBIs, concussions, and chronic traumatic encephalopathy (CTE)

A traumatic brain injury (TBI) occurs when the brain is injured by an external source from a significant acceleration or deacceleration, impact, or blast wave. TBIs are a leading cause of death and disability worldwide [1]. Sports-related TBIs make up to one-third of all causes of TBIs [2]. Mild TBIs are called concussions and are the most common types of TBIs. The Center of Disease Control estimates that there are around 300,000 sports-related concussions per year in the USA [3]. However, this number only includes athletes who have lost consciousness, which occurs in only about 10% of concussions [4]. The real number may be more than several million per year [5]. The vast majority of people who suffer a TBI do not immediately die from the primary injury, i.e., the damage directly to the brain tissue and blood vessels. Instead, most consequences occur from the secondary injury largely due to excessive inflammation and production of reactive oxygen species.

The secondary injuries may result in post-concussion syndrome in which the symptoms continue to last for months to more than a year after a TBI. Frequent TBIs increase the risk for developing the neurogenerative disease, chronic traumatic encephalopathy [6]. It normally takes eight to ten years after repetitive concussions for the stages of CTE to appear. The symptoms of these stages include confusion, headaches, memory loss, impulsive behavior, depression, suicidality, etc. [6].

3. Diagnosis and testing for TBIs

Diagnosis of TBIs may include neuroimaging such as a computed tomography (CT) scan, functional magnetic resonance imaging (fMRI), single photon emission computed tomography (SPECT), and positron emission tomography (PET) scans. However, most concussions are not usually associated with visible lesions that can be detected by current imaging techniques [7]. Unfortunately, there is no urine, saliva, or blood test that can confirm either the existence of a TBI or recovery from a TBI [8]. Accordingly, cognitive functional assessments are imperative to understanding the prognosis and recovery of TBIs [7]. The most widely used psychometric test is the “Immediate post-concussion assessment and cognitive testing” abbreviated as “ImPACT” [9]. Another method that can be useful is a neuro-diagnostic called Brain Gauge by Cortical Metrics. This is also an FDA-approved device that has been demonstrated to be an effective tool for monitoring TBIs. It measures eight essential components of brain health including, speed, focus, fatigue, accuracy, sequencing, timing, perception, plasticity, and connectivity [10].

In one study, over 200 student athletes were tracked post-concussion with the Brain Gauge and the results were compared to other methods including ImPACT and balance testing, and it was found that the Brain Gauge was highly sensitive and accurate in the measurements. This is largely because of the high precision and accuracy of measuring reaction time, which is an objective indicator of concussions and recovery [11]. The precision (0.33 milliseconds) is approximately 1000× more precise than visual reaction time methods. The Brain Gauge has been validated by over 50 years of clinical studies and is currently used by more than 50 universities around the world. It is also used by the Office of Naval Research and Applied Research Associates to help improve diagnosis and treatment of military personnel exposed to blasts. Accordingly, in addition to conventional ImPACT testing fMRI, CT and PET scans, the Brain Gauge may represent an important tool for concussion diagnostics and to monitor improvements in cognitive function over time.

4. Molecular pathophysiology of TBIs

Despite having a mass of only 2% of the body, the brain constitutes about 20% of the normal resting metabolic rate. In other words, the brain consumes about 20% of the available oxygen in order to maintain normal cognitive function [12]. In order to receive this much oxygen, the brain receives a high proportion (15%–20%) of the blood from cardiac output [13]. However, after adolescence, cerebral blood flow declines with normal aging at around 0.5% a year [14]. As a logical consequence of the decreased blood flow are the impairments to cognitive function and increased dementia that similarly increase with aging [15]. Additionally, middle-aged subjects with metabolic syndrome have decreased cognitive function and 15% lower blood flow compared to their healthy age-matched counterparts [16].

As expected, traumatic brain injuries (TBIs) also dysregulate and impair cerebral blood flow [17]. Normally cerebral autoregulation maintains adequate brain perfusion during systemic changes in blood pressure. However, TBIs impair the brain’s autoregulation of blood flow, which is correlated with poor cognitive function [17]. The decreased cerebral blood flow predicts the severity, cognitive dysfunction, and recovery from a TBI [18]. The reduced brain blood flow means a reduction in oxygen and glucose, which leads to a pathological energy crisis [19]. Reduced oxygen impairs mitochondrial activity, thus decreasing adenosine triphosphate (ATP) from oxidative phosphorylation. Under low oxygen conditions, anaerobic glycolysis would normally increase to ensure sufficient ATP; however, although glycolysis increases, the lower blood supply limits glucose availability resulting in further reductions in ATP and subsequent neuronal dysfunction [20].

The decrease in ATP production decreases Na+/K+ ATPase pump activity resulting in membrane depolarization and dysregulation of potassium, calcium, and sodium ions. As a consequence, high levels of the excitatory neurotransmitter glutamate are released resulting in excessive neuronal stimulation leading to more ion imbalances. This is called glutamate excitotoxicity since the process is toxic to the cells and leads to cellular death [21]. The increased calcium levels directly stimulate apoptotic pathways resulting in more cell death. Calcium also activates various inflammatory transcription factors such as the proto-oncogene c-FOS, (nuclear factor of activated T-cells) NFAT, (nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), toll like receptor 4 (TLR4), high-mobility group box 1 (HMGB1), protein kinase C (PKC), and inducible nitric oxide synthase (iNOS). The increased inflammation further triggers neuronal apoptosis. Additionally, the ion imbalances, high inflammation, and activation of protein kinase C and iNOS result in over production of reactive oxygen species leading to direct damage to deoxyribonucleic acid (DNA), ribonucleic acid (RNA), proteins, and cell membranes, which further increases inflammation, mitochondrial dysfunction, and cell death. The pathological situation worsens as the blood flow decreases further. This not only impairs oxygen and substrate availability, but also the ability to remove cellular metabolic waste including excess neurotransmitters and inflammatory mediators. Fig. 1 provides a recapitulation of primary and secondary TBI pathology and related sequala along with various proposed interventions.

Fig. 1.

Pathophysiology of TBI injury and related consequences and interventions.

5. Treatment for TBIs

Immediate treatment of a TBI is imperative to help reduce the secondary injuries previously discussed. However, there is no known effective treatment or medications for TBI. Most recommendations simply include physical rest while slowly transitioning from light work back to normal activity once it appears that cognitive function has been restored [8]. However, this does not address the pathological cascades resulting in secondary brain injury such as oxidative stress, inflammation, reduced blood flow, metabolic dysregulation, glutamate excitotoxicity, and neuronal apoptosis. Conventional antioxidants and anti-inflammatories are often ineffective at preventing or treating human diseases [22], but still may have some benefit for TBI [23].

There have been many preclinical studies in various animal models using different bioactive molecules. For example, in a mouse model of TBI-induced by controlled cortical impact, treatment with Coriolus versicolor and Hericium erinaceus from mushrooms restored behavioral alterations and decreased the neuroinflammatory and oxidative stress [24]. In a similar TBI-mouse model, administration of artesunate from the Chinese plant Artemisia annua was able to favorably modulate neurotropic factors and suppress NF-κB and the nucleotide-binding oligomerization domain, leucine-rich-containing family, pyrin domain-containing 3 (NLRP3) inflammasome complex [25]. However, despite a variety of animal models of TBIs [26], there is a fundamental disconnect between these studies and successful translation to treating people for TBIs [27]. One of the challenges with treating TBIs with pharmaceuticals/nutraceuticals is that they do not easily penetrate the blood-brain barrier because of their size, charge, and polarity [28].

6. Molecular hydrogen

Molecular hydrogen (H2 gas) has recently emerged as an ergogenic and medicinal therapeutic for exercise performance [29] and clinical medicine [30], respectively. Hydrogen is the smallest molecule in the universe with no charge or polarity, which gives it the fastest rate of diffusion and easy penetration through cell membranes, including the intracellular compartments such as the mitochondria and nucleus, and easily diffuses through the blood-brain barrier [30]. Hydrogen was first shown to be neuroprotective in 2007, when an article published in Nature Medicine demonstrated that H2 could markedly suppress brain damage in a rat model of cerebral infarction induced by a middle cerebral artery occlusion [31]. The article further demonstrated that H2 acts as a selective antioxidant in that it only reduces the highly toxic oxidants and does not neutralize the beneficial signaling molecules [31]. Since then, around 2000 publications and over 100 human clinical studies have added credence to the therapeutic effects of H2. However, the exact primary targets remain elusive, and the main mechanisms have largely been attributed to hydrogen’s unique selective antioxidant, anti-inflammatory, and cell-signal modulating activities.

Hydrogen administration for TBIs and concussions

The chemical properties and biological effects of hydrogen make it an attractive molecule for the treatment of TBIs. There are many therapeutic effects of H2 that could feasibly be of benefit in protecting against TBIs, including protection against glutamate-induced excitotoxicity [32], regulation of aberrant calcium signaling [33], inhibition of mitochondrial permeability transition pores [34], suppression of proinflammatory cytokines and proteins that are often expressed in TBIs (e.g., cFOS, NFAT, NF-κB, TLR4, HBMG1, NLRP3, protein kinase C, etc.) [30], and other conceivable benefits as has been recently reviewed [35]. A number of studies have specifically investigated the effects of H2 administration on TBIs and reported favorable results. For example, a study from University of Washington found that drinking hydrogen water was protective against the neurodegenerative changes induced by a TBI [36]. They used an experimental model of controlled cortical impact, which induced significant neuropathological aberrations. However, ingestion of hydrogen-rich water reversed TBI-induced edema by 50%, completely blocked pathological tau expression, attenuated inflammatory cytokines, reversed the pathological changes in aquaporin-4, HIF-1, MMP-2, and MMP-9. Moreover, it was found that hydrogen treatment either increased or preserved the mitochondrial ATP levels independent of the electron transport chain [36]. Similarly, another group using a rat model (n = 50) of free-fall impact found that H2 significantly improved the neurological severity score compared to the TBI group without hydrogen. Mechanistically it was found that expression of inflammatory markers tumor necrosis factor alpha (TNF-α), interleukin 1 beta (IL-1β), reactive oxygen species (ROS) levels, and markers of apoptosis all significantly decreased [37]. Correspondingly, another report found that H2 significantly increased the 7-day survival time and reduced neurological deficits [38]. This was mediated by H2-enhanced translocation of cytoprotective Nrf2 protein into the nucleus resulting in decreased oxidative stress [38]. Table 1 (Ref. [36,38-50]) provides a summary of the symptomatic, cellular, and molecular benefits of H2 on TBIs and concussions.

Table 1.Benefits of H2 for TBIs and concussions.
Phenotypic, cellular and mechanistic effects of H2 on TBI/concussions Reference
Symptomatic/phenotypic benefits
Improved neurofunctional outcome [39]
Improved neurological severity score [38]
Improve neurological function [40, 41]
Improved neurobehavioral function [41]
Prevention of neurological dysfunction [42]
Reduced neurological deficits [38, 43]
Improved cognitive performance and brain plasticity [44]
Increased 7-day survival rates [38]
Cellular/tissue benefits
Reduced brain edema [41, 42, 43, 44, 45, 46]
Reduced lesion volume [40]
Reduced tissue damage/cell death [39]
Reduced blood-brain barrier permeability/disruption [40, 41, 42]
Increased angiogenesis/capillarization [46]
Molecular benefits
Reduced mast cell activation [41]
Reduced microglia activation and neuroinflammation [47]
Reduced apoptosis (increased Bcl-2/Bax ratio, and decreased caspase-3) [39, 43, 48]
Reduced aquaporin expression [36, 45]
Reduced pathological tau expression [36]
Reduced silent information regulator 2 (sir2) [44]
Reduced inflammation (e.g., TNFα, IL-1β, HMGB1) [36, 42, 48]
Reduced reactive oxygen species [40, 43, 44, 48]
Increased antioxidant status [40, 41, 48]
Increased brain-derived neurotropic factor [44]
Increased ATP levels [36]
Regulation of autophagy activation [49, 50]
Bcl-2, B-cell lymphoma protein 2; Bax, Bcl2 associated X-protein.

In addition to the studies directly using H2 to treat TBIs, there are also supportive clinical studies on the use of H2 for other brain injuries that share common pathologies. For example, human clinical studies have demonstrated that hydrogen improves mild cognitive impairments [51], cerebral infarction [52], and improves mood and anxiety in healthy subjects [53]. As mentioned earlier, subjects with metabolic syndrome tend to have lower cerebral blood flow [16], and several clinical studies have demonstrated that drinking hydrogen water can improve this condition [54-56]. Another human study in newborn infants (n = 40) that suffered from reduced cerebral blood flow were administered hydrogen water two days after birth daily for ten days [57]. Hydrogen water was shown to be safe and lowered the inflammatory markers TNFα and IL-6 and significantly decreased neuron–specific enolase, a sensitive marker for nerve cell damage [57].

7. Role of nitric oxide in TBIs and concussions

Another medical gas that has shown therapeutic effects for TBIs is nitric oxide (NO) [58]. Nitric oxide is primarily produced via nitric oxide synthase (NOS) enzymes, of which there are three isoforms, namely, inducible NOS (iNOS), neuronal NOS (nNOS), and endothelial NOS (eNOS) [59]. Nitric oxide levels gradually decrease with age; a 70-year-old may have a 75% reduction in nitric oxide levels compared to a healthy 20-year-old [60]. This may help explain why cerebral blood flow also decreases with age [14,15]. One principal reason why nitric oxide can improve TBI is because it is able to increase cerebral blood flow, which is significantly reduced following a TBI [17]. Accordingly, nitric oxide also has many beneficial effects if its production and metabolism are regulated and in the desired locations where it can increase the needed blood flow [58]. One study found that when nitric oxide was administered post-TBI via inhalation in mice, there was a significantly reduced lesion volume and brain edema with less disruption to the blood-brain barrier and improved neurological function [61]. Similarly, another group reported that nitric oxide administration significantly protected against TBI-induced neuronal cell necrosis and maintained cerebral autoregulation of blood flow in juvenile pigs [62].

Pathological effects of nitric oxide

However, nitric oxide also has a dark side as its dysregulation mediates many of the pathological consequences of TBIs. A decreased eNOS activity results in decreased blood flow and subsequent reductions in oxygen and glucose availability, and decreased removal of metabolic waste and cellular debris. The increased inflammation leads to an increased iNOS activation, which is expressed in macrophages and glial cells [63]. Unlike eNOS, increased iNOS expression is often harmful and contributes to the pathophysiology of secondary TBI injuries [63]. The high levels of NO increase the reactions with superoxide, which forms peroxynitrite (ONOO). This highly oxidative molecule damages mitochondria, the vascular endothelium, and smooth muscle cells [64]. Additionally, the high iNOS activity results in local substrate depletion for eNOS activity, paradoxically resulting in NO depletion [58].

In humans suffering severe TBI, the levels of arginine and citrulline were significantly reduced compared to the control group [65]. Accordingly, increasing or preserving arginine availability is paramount in improving the prognosis of TBIs. This can be attenuated by increasing arginine availability via supplementation [66]. Supplementation with citrulline is more effective at increasing plasma arginine and NO levels compared to supplementing with arginine [67]. Low levels of citrulline may also lead to NOS uncoupling, which induces further oxidative and cellular damage [68].

8. Molecular hydrogen and nitric oxide combination

The novel combination of these two medical gases has important clinical implications [69]. For example, molecular hydrogen is able to attenuate the aforementioned dark side of nitric oxide and regulate its production and metabolism. This includes (i) enhanced expression of protective eNOS, (ii) decreased inflammatory mediators that impair NO signaling, (iii) decreased pathological iNOS activity, (iv) reductions in ONOO formation, and (v) protection against ONOO as evidenced by the elimination of nitrotyrosine levels when the two gases were administered simultaneously [70]. Additionally, H2 can enhance the benefits of NO by regulating its production and increasing its circulating half-life while also enhancing its therapeutic effects [71].

9. Methods and results for a novel H2/NO functional beverage

In order to evaluate the potential of an H2/NO combination on cognitive function using neurocognitive assessments, we used a beverage called Hydro Shot. This is a zero-calorie, functional beverage containing nitric-oxide-stimulating citrulline that has been infused with molecular hydrogen. The concentration of H2 is above 2 mg/L as determined via gas chromatography (H2 Analytics, Las Vegas, USA; SRI 8610C; California, USA). All ingredients have a high safety profile and are designated as GRAS (Generally Recognized as Safe) by the USFDA. It was previously reported [71] that this novel H2-infused, nitric oxide-producing functional beverage significantly increased nitric oxide production and blood flow [72] with a corresponding increase in exercise performance and cognitive function [71]. Here, we briefly report the effects of Hydro Shot on various cognitive indices using different neurocognitive testing methods as explained below that are used to indicate the presence of TBIs and concussions. The cognitive function of six male subjects (>65 years) was tested. All tests were carried out in an open label, non-blinded fashion Since results were similar, we presented the computer-generated graphics for a 74-year-old male. Due to the sample size and methodology of this study, caution should be employed when interpreting these preliminary results.

9.1 H2/NO beverage improves clinical ImPACT scores

In order to assess the effects of the functional beverage on cognitive function related to TBIs, the FDA-approved medical device, ImPACT was used (ImPACT Applications, Inc., Coralville, IA, USA) As mentioned, this widely used computer software gives a battery of neurocognitive tests for concussion care. A clinical ImPACT report was generated, and the average value of each category was determined. The composite score consisted of five parts (memory verbal, memory visual, visual-motor speed, reaction time, and impulse control). These values were totaled to find the average so that each category as a whole can be compared directly to each other. Fig. 2 shows the results of completing the assessment with and without Hydro Shot. As noted in the figure, this novel functional beverage improved the ImPACT clinical scores indicating its ability to improve functional cognition.

Fig. 2.

Effects of functional beverage on clinical ImPACT scores. Ingestion of beverage improved ImPACT scores compared to baseline.

9.2 Hydro shot improves cognitive scores using brain gauge

It was previously reported that Hydro Shot significantly improved cognitive function as assessed by Brain Gauge (Cortical Metrics, Chapel Hill, NC, USA) [71]. As discussed earlier, the Brain Gauge cognitive assessment tool has been validated by many studies and serves as an important indicator of TBIs. Fig. 3 illustrates the effects of the novel functional beverage on cognitive function using a radar chart.

Fig. 3.

Radar charts of cognitive function. (A) Without beverage. (B) With beverage. Cognitive scores were significantly improved above baseline following ingestion of the novel beverage.

The H2/NO beverage induced significant improvements in the multivariant cognitive indices as illustrated in the radar chart. The scores were higher and also more symmetrical and balanced. These results indicate that this novel beverage can improve cognitive function as assessed by neuropscyometric testing.

10. Discussion

TBIs are a leading cause of death and disability worldwide [1]. Various diagnostic and assessment tools are available including neuroimaging techniques (e.g., fMRI, CT and PET scans, etc.), and computer software neuropsychometric testing. However, neuroimaging methods are expensive, time consuming, and do not always detect the presence of existing TBIs. The neuropsychometric assessments, such as ImPACT and Brain Gauge, appear to be more accurate in diagnosing and monitoring TBIs. Brain Gauge has a high level of sensitivity, accuracy, and precision for assessing cognitive function. We report that Hydro Shot significantly improved the clinical scores using ImPACT testing as well as the Brain Gauge. The significant improvements from Hydro Shot may be due to its ability to increase nitric oxide production and subsequent cerebral blood flow as well as the neuroprotective effects of molecular hydrogen.

The level of cerebral blood flow may predict the recovery, injury severity and cognitive function from TBIs. The reduction in cerebral blood flow is largely due to reductions in nitric oxide. Nitric oxide plays a key role in the prognosis, recovery, and pathogenesis of TBIs. Molecular hydrogen also has important benefits for TBIs and concussions at improving neurological outcomes and reduced brain damage. These benefits are primarily due to the unique properties of hydrogen including (i) rapid diffusion and penetration through all cell membranes and subcellular compartments (e.g., nucleus, mitochondria, and blood-brain barrier), (ii) selective antioxidant activity, (iii) selective anti-inflammatory activity, (iv) prevention of pathological apoptosis, (v) favorable effects on microRNA and gene expression, (vi) improved mitochondrial function, (vii) regulation of nitric oxide production and metabolism, (viii) enhancement of nitric oxide’s therapeutic effects, (ix) suppression of excess iNOS activity, and (x) protection against nitrosative stress induced by ONOO.

The cellular damage induced by TBIs is due to both primary and secondary injuries to the brain. Prevention is the best strategy for primary injuries, but once it occurs, then treatment of secondary injuries is paramount. However, no approved or effective medical treatments for TBIs currently exist. The secondary injuries occur due to increased oxidative stress, inflammation, and impaired metabolism largely attributed to reductions in cerebral blood flow, which decreases glucose and oxygen availability. Cerebral blood flow also declines with age in accordance with the decline in nitric oxide levels. Physical exercise and healthy dietary choices increase global and regional cerebral blood flow and improve cognitive functioning [13]. The studies on the effects of molecular hydrogen and nitric oxide make it an attractive combination for TBIs and concussions.

11. Conclusions

Molecular hydrogen has emerged as an important medical gas with favorable physicochemical properties that make it ideal for the treatment of secondary TBIs. This is supported by pre-clinical studies and relevant human clinical studies. Similarly, nitric oxide has essential biological effects to treat TBIs but not without undesirable side effects. The novel approach of combining molecular hydrogen with nitric oxide may significantly improve the prognosis of TBIs by exerting individual and potential synergistic therapeutic effects with hydrogen mitigating nitric oxide toxicity.

The preliminary results obtained with the novel H2/NO functional beverage, Hydro Shot, indicate that such an intervention may offer improvements in not only physical exercise, but also exert neuroprotection against a variety of traumatic brain injuries. However, well-designed, placebo-controlled clinical studies are strongly warranted to further investigate the potential use of the novel and simple approach of using these two medical gases (H2 and NO) administered via this unique beverage formulation. It is also recommended that neuroimaging technology be employed to determine the effects of this H2/NO combination on cerebral blood flow, oxygen concentration, and cerebral activity. Additionally, in vitro studies are encouraged to elucidate the molecular mechanisms responsible for the observed therapeutic effects of this novel approach.


CT, computed tomography; CTE, chronic traumatic encephalopathy; eNOS, endothelial nitric oxide synthase; HIF-1, hypoxia inducible factor; IL-1β, interleukin-1 beta; IL-6, interleukin 6; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; NFAT, nuclear factor of activated T cells; nNOS, neuronal nitric oxide synthase; Nrf2, nuclear factor erythroid 2-related factor 2; PKC, protein kinase C; iNOS, inducible nitric oxide synthase; ROS, reactive oxygen species; TBI, traumatic brain injury; TLR4, Toll-like receptor 4; HMBG1, high mobility group box 1 protein; TNFα, tumor necrosis factor alpha.

Author contributions

TWL, JK, MLM conceived and designed the experiments; JK and MLM performed the experiments; TWL and JK analyzed the data; TWL and JK wrote the manuscript. All authors approved the final manuscript.

Ethics approval and consent to participate

Not applicable.


We thank H2 Beverages Inc., PO Box 940283, Plano, TX 75094–0283, USA. for providing product for testing, and also Kurt H. Ruppman Sr. for supporting information.


This research received no external funding.

Conflict of interest

MLM is a scientific advisor to the company. TWL reports personal fees from medical/academic conferences including travel reimbursement, honoraria, and speaking and consultancy fees from various academic and commercial entities regarding molecular hydrogen. All other authors report no conflict of interest.

Schönberger M, Ponsford J, Gould KR, Johnston L. The temporal relationship between depression, anxiety, and functional status after traumatic brain injury: a cross-lagged analysis. International Neuropsychological Society. 2011; 17: 781–787.
Theadom A, Mahon S, Hume P, Starkey N, Barker-Collo S, Jones K, et al. Incidence of sports-related traumatic brain injury of all severities: a systematic review. Neuroepidemiology. 2020; 54: 192–199.
Cassidy JD, Carroll LJ, Peloso PM, Borg J, von Holst H, Holm L, et al. Incidence, risk factors and prevention of mild traumatic brain injury: results of the WHO collaborating centre task force on mild traumatic brain injury. Rehabilitation Medicine. 2004; 43: 28–60.
Cantu RC. Second-impact syndrome. Clinical Journal of Sport Medicine. 1998; 17: 37–44.
Langlois JA, Rutland-Brown W, Wald MM. The epidemiology and impact of traumatic brain injury: a brief overview. Head Trauma Rehabilitation. 2006; 21: 375–378.
Fesharaki-Zadeh A. Chronic traumatic encephalopathy: a brief overview. Frontiers in Neurology. 2019; 10: 713.
Graham R, Rivara FP, Ford MA, Spicer CM. Sports-related cxoncussions in youth: improving the science, changing the culture. National Academies Press. 2014.
Kamins J, Bigler E, Covassin T, Henry L, Kemp S, Leddy JJ, et al. What is the physiological time to recovery after concussion? A systematic review. British Journal of Sports Medicine. 2017; 51: 935–940.
Alsalaheen B, Stockdale K, Pechumer D, Broglio SP. Validity of the immediate post concussion assessment and cognitive testing (ImPACT). Sports Medicine. 2016; 46: 1487–1501.
Tommerdahl M, Lensch R, Francisco E, Holden J, Favorov O. The brain gauge: a novel tool for assessing brain health. Journal of Science and Medicine. 2019; 1: 1–19.
Tommerdahl M, Francisco E, Holden J, Lensch R, Tommerdahl A, Kirsch B, et al. An accurate measure of reaction time can provide objective metrics of concussion. Journal of Science and Medicine. 2020; 2.
Raichle ME, Gusnard DA. Appraising the brain’s energy budget. Proceedings of the National Academy of Sciences of the United States of America. 2002; 99: 10237–10239.
Joris PJ, Mensink RP, Adam TC, Liu TT. Cerebral blood flow measurements in adults: a review on the effects of dietary factors and exercise. Nutrients. 2018; 10: 530.
Leenders KL, Perani D, Lammertsma AA, Heather JD, Buckingham P, Healy MJ, et al. Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. Brain. 1990; 113: 27–47.
Mak HK, Chan Q, Zhang Z, Petersen ET, Qiu D, Zhang L, et al. Quantitative assessment of cerebral hemodynamic parameters by QUASAR arterial spin labeling in alzheimer’s disease and cognitively normal elderly adults at 3-tesla. Alzheimer’s Disease. 2012; 31: 33–44.
Birdsill AC, Carlsson CM, Willette AA, Okonkwo OC, Johnson SC, Xu G, et al. Low cerebral blood flow is associated with lower memory function in metabolic syndrome. Obesity. 2013; 21: 1313–1320.
Ding K, Tarumi T, Tomoto T, McColloster M, Le T, Dieppa M, et al. Impaired cerebral blood flow regulation in chronic traumatic brain injury. Brain Resport. 2020; 1743: 146924.
Ware JB, Dolui S, Duda J, Gaggi N, Choi R, Detre J, et al. Relationship of cerebral blood flow to cognitive function and recovery in early chronic traumatic brain injury. Neurotrauma. 2020; 37: 2180–2187.
Bowen AP. Second impact syndrome: a rare, catastrophic, preventable complication of concussion in young athletes. Emergency Nursing. 2003; 29: 287–289.
Mahooti N. Sports-related concussion: acute management and chronic postconcussive issues. Child and Adolescent Psychiatric Clinics of North America. 2018;27:93–108.
Lipton P. Ischemic cell death in brain neurons. Physiological Review. 1999; 79: 1431–568.
Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. Journal of the American Medical Association. 2007; 297: 842–857.
Wood J, Fabian TC, Mangiante EC. Penetrating neck injuries: recommendations for selective management. Trauma. 1989; 29: 602–605.
D’Amico R, Trovato Salinaro A, Fusco R, Cordaro M, Impellizzeri D, Scuto M, et al. Hericium erinaceus and coriolus versicolor modulate molecular and biochemical changes after traumatic brain injury. Antioxidants. 2021; 10: 898.
Gugliandolo E, D’Amico R, Cordaro M, Fusco R, Siracusa R, Crupi R, et al. Neuroprotective effect of artesunate in experimental model of traumatic brain injury. Frontiers in Neurology. 2018; 9: 590.
Bodnar CN, Roberts KN, Higgins EK, Bachstetter AD. A systematic review of closed head injury models of mild traumatic brain injury in mice and rats. Neurotrauma. 2019; 36: 1683–1706.
Iboaya A, Harris JL, Arickx AN, Nudo RJ. Models of traumatic brain injury in aged animals: a clinical prspective. Neurorehabil Neural Repair. 2019; 33: 975–988.
Persidsky Y, Ramirez SH, Haorah J, Kanmogne GD. Blood-rain barrier: structural components and function under physiologic and pathologic conditions. Neuroimmune Pharmacol. 2006; 1: 223–236.
LeBaron TW, Laher I, Kura B, Slezak J. Hydrogen gas: from clinical medicine to an emerging ergogenic molecule for sports athletes. Canadian Journal of Physiology and Pharmacology. 2019; 97: 737–807.
LeBaron TW, Kura B, Kalocayova B, Tribulova N, Slezak J. A new approach for the prevention and treatment of cardiovascular disorders. Molecular Hydrogen Significantly Reduces the Effects of Oxidative Stress. Molecules. 2019; 24: 2076.
Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nature Medicine. 2007; 13: 688–694.
Wei L, Ge L, Qin S, Shi Y, Du C, Du H, et al. Hydrogen-rich saline protects retina against glutamate-induced excitotoxic injury in guinea pig. Experimental Eye Research. 2012; 94: 117–127.
Han L, Tian R, Yan H, Pei L, Hou Z, Hao S, et al. Hydrogen-rich water protects against ischemic brain injury in rats by regulating calcium buffering proteins. Brain Research. 2015; 1615: 129–138.
Yoshida A, Asanuma H, Sasaki H, Sanada S, Yamazaki S, Asano Y, et al. H(2) mediates cardioprotection via involvements of K(ATP) channels and permeability transition pores of mitochondria in dogs. Cardiovascular Drugs and Therapy. 2012; 26: 217–226.
Hu HW, Chen ZG, Liu JG, Chen G. Role of hydrogen in traumatic brain injury: a narrative review. Medical Gas Research. 2021; 11: 114–120.
Dohi K, Kraemer BC, Erickson MA, McMillan PJ, Kovac A, Flachbartova Z, et al. Molecular hydrogen in drinking water protects against neurodegenerative changes induced by traumatic brain injury. PLoS ONE. 2014; 9: e108034.
Fu J, Lan Q, Wang D, Wang Y, Liu Y. Effect of hydrogen-rich water on the chondriosome damage and cytokines in brain tissue of rats with traumatic brain injury. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018; 30: 317–321.
Yuan J, Wang D, Liu Y, Chen X, Zhang H, Shen F, et al. Hydrogen-rich water attenuates oxidative stress in rats with traumatic brain injury via Nrf2 pathway. Surgical Research. 2018; 228: 238–246.
Hong Y, Shao A, Wang J, Chen S, Wu H, McBride DW, et al. Neuroprotective effect of hydrogen-rich saline against neurologic damage and apoptosis in early brain injury following subarachnoid hemorrhage: possible role of the Akt/GSK3beta signaling pathway. PLoS ONE. 2014; 9: e96212.
Ji X, Tian Y, Xie K, Liu W, Qu Y, Fei Z. Protective effects of hydrogen-rich saline in a rat model of traumatic brain injury via reducing oxidative stress. Journal of Surgical Research. 2012; 178: e9–16.
Zhan Y, Chen C, Suzuki H, Hu Q, Zhi X, Zhang JH. Hydrogen gas ameliorates oxidative stress in early brain injury after subarachnoid hemorrhage in rats. Critical Care Medicine. 2012; 40: 1291–1296.
Tian R, Hou Z, Hao S, Wu W, Mao X, Tao X, et al. Hydrogen-rich water attenuates brain damage and inflammation after traumatic brain injury in rats. Brain Research. 2016; 1637: 1–13.
Li TT, Yang WC, Wang YZ, Sun T, Cao HL, Chen JF, et al. Effects of a high concentration of hydrogen on neurological function after traumatic brain injury in diabetic rats. Brain Research. 2020; 1730: 146651.
Hou Z, Luo W, Sun X, Hao S, Zhang Y, Xu F, et al. Hydrogen-rich saline protects against oxidative damage and cognitive deficits after mild traumatic brain injury. Brain Research Bulletin. 2012; 88: 560–565.
Chen X, Wang D, Liu Y, Yuan J, Zhang H. Effects of hydrogen-rich water on the expression of aquaporin 1 in the cerebral cortex of rat with traumatic brain injury. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2016; 28: 460–464.
Liu Y, Wang D, Chen X, Yuan J, Zhang H, Fu J, et al. Effect of hydrogen-rich water on the angiogenesis in lesion boundary brain tissue of traumatic brain injury-challenged rats. International Journal of Clinical and Experimental Pathology. 2017; 10: 3807–3815.
Zhao QH, Xie F, Guo DZ, Ju FD, He J, Yao TT, et al. Hydrogen inhalation inhibits microglia activation and neuroinflammation in a rat model of traumatic brain injury. Brain Research. 2020; 1748: 147053.
Huang Y, Xie KL, Li JP, Xu N, Gong G, Wang GL, et al. Beneficial effects of hydrogen gas against spinal cord ischemia-reperfusion injury in rabbits. Brain Research. 2011; 1378: 125–136.
Wang Y, Wang L, Hu T, Wang F, Han Z, Yin Z, et al. Hydrogen improves cell viability partly through inhibition of autophagy and activation of PI3K/Akt/GSK3beta signal pathway in a microvascular endothelial cell model of traumatic brain injury. Neurological Research. 2020; 42: 487–496.
Jiang X, Niu X, Guo Q, Dong Y, Xu J, Yin N, et al. FoxO1-mediated autophagy plays an important role in the neuroprotective effects of hydrogen in a rat model of vascular dementia. Behavioural Brain Research. 2019; 356: 98–106.
Nishimaki K, Asada T, Ohsawa I, Nakajima E, Ikejima C, Yokota T, et al. Effects of molecular hydrogen assessed by an animal model and a randomized clinical study on mild cognitive impairment. Current Alzheimer Research. 2018; 15: 482–492.
Ono H, Nishijima Y, Ohta S, Sakamoto M, Kinone K, Horikosi T, et al. Hydrogen gas inhalation treatment in acute cerebral infarction: a randomized controlled clinical study on safety and neuroprotection. Stroke and Cerebrovascular Diseases. 2017; 26: 2587–2594.
Mizuno K, Sasaki AT, Ebisu K, Tajima K, Kajimoto O, Nojima J, et al. Hydrogen-rich water for improvements of mood, anxiety, and autonomic nerve function in daily life. Medical Gas Research. 2017; 7: 247–255.
LeBaron TW, Singh RB, Fatima G, Kartikey K, Sharma JP, Ostojic SM, et al. The effects of 24-week, high-concentration hydrogen-rich water on body composition, blood lipid profiles and inflammation biomarkers in men and women with metabolic syndrome: a randomized controlled trial. Diabetes Metabolic Syndrome and Obesity. 2020; 13: 889–896.
Nakao A, Toyoda Y, Sharma P, Evans M, Guthrie N. Effectiveness of hydrogen rich water on antioxidant status of subjects with potential metabolic syndrome—an open label pilot study. Clinical Biochemistry and Nutrition. 2010; 46: 140–149.
Song G, Li M, Sang H, Zhang L, Li X, Yao S, et al. Hydrogen-rich water decreases serum LDL-cholesterol levels and improves HDL function in patients with potential metabolic syndrome. Journal of Lipid Research. 2013; 54: 1884–1893.
Yang L, Li D, Chen S. Hydrogen water reduces NSE, IL-6, and TNF-alpha levels in hypoxic-ischemic encephalopathy. Open Medicine. 2016; 11: 399–406.
Cherian L, Hlatky R, Robertson CS. Nitric oxide in traumatic brain injury. Brain Pathology. 2004; 14: 195–201.
Wijnands KA, Castermans TM, Hommen MP, Meesters DM, Poeze M. Arginine and citrulline and the immune response in sepsis. Nutrients. 2015; 7: 1426–1463.
Torregrossa AC, Aranke M, Bryan NS. Nitric oxide and geriatrics: implications in diagnostics and treatment of the elderly. Geriatric Cardiology. 2011; 8: 230–242.
Terpolilli NA, Kim SW, Thal SC, Kuebler WM, Plesnila N. Inhaled nitric oxide reduces secondary brain damage after traumatic brain injury in mice. Cerebral Blood Flow & Metabolism. 2013; 33: 311–318.
Hekierski H, Pastor P, Curvello V, Armstead WM. Inhaled nitric oxide protects cerebral autoregulation and reduces hippocampal neuronal cell necrosis after traumatic brain injury in newborn and juvenile pigs. Neurotrauma. 2019; 36: 630–638.
Garry PS, Ezra M, Rowland MJ, Westbrook J, Pattinson KT. The role of the nitric oxide pathway in brain injury and its treatment—from bench to bedside. Experimental Neurology. 2015; 263: 235–243.
Moro MA, Almeida A, Bolanos JP, Lizasoain I. Mitochondrial respiratory chain and free radical generation in stroke. Free Radical Biology and Medicine. 2005; 39: 1291–1304.
Jeter CB, Hergenroeder GW, Ward NH, Moore AN, Dash PK. Human traumatic brain injury alters circulating L-arginine and its metabolite levels: possible link to cerebral blood flow, extracellular matrix remodeling, and energy status. Neurotrauma. 2012; 29: 119–127.
Huk I, Nanobashvili J, Neumayer C, Punz A, Mueller M, Afkhampour K, et al. L-arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle. Circulation. 1997; 96: 667–675.
Schwedhelm E, Maas R, Freese R, Jung D, Lukacs Z, Jambrecina A, et al. Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. British Journal of Clinical Pharmacology. 2008; 65: 51–59.
Ware LB, Magarik JA, Wickersham N, Cunningham G, Rice TW, Christman BW, et al. Low plasma citrulline levels are associated with acute respiratory distress syndrome in patients with severe sepsis. Critical Care. 2013; 17: R10.
Hayashida K, Miyara SJ, Shinozaki K, Takegawa R, Yin T, Rolston DM, et al. Inhaled gases as therapies for post-cardiac arrest syndrome: a narrative review of recent developments. Frontiers in Medicine. 2020; 7: 586229.
Liu H, Liang X, Wang D, Zhang H, Liu L, Chen H, et al. Combination therapy with nitric oxide and molecular hydrogen in a murine model of acute lung injury. Shock. 2015; 43: 504–511.
Lebaron TW, Kharman J, McCullough ML. Effects of an H_2-infused, nitric oxide-producing functional beverage on exercise and cognitive performance. Journal of Science and Medicine. 2021; 3: 1–15.
LeBaron TW, McCullough ML, Ruppman Sr KH. A novel functional beverage for COVID-19 and other conditions: hypothesis and preliminary data, increased blood flow, and wound healing. Translational Science. 2020; 6: 1–6.
Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Back to top